In the News

Read the latest articles featuring MTPConnect.

Untapped potential in clinical trials sector

AusInnovation | 20 May 2021

Half a decade of domestic growth in the clinical trials sector has failed to attract a greater share of global industry-sponsored trials to Australia, according to a new report from the MedTech and pharmaceutical growth centre, which touts the sector’s potential in the COVID recovery.

MTPConnect launches voucher program to support medical manufacturing

Manufacturers Monthly | 17 May 2021

MTPConnect, Australia’s growth centre for medical technologies and pharmaceuticals sector, has launched a new voucher program to boost the manufacture of medical products in Western Australia.  

MedTech and pharma grants open in WA 

AusInnovation | 17 May 2021 

Western Australian developers and manufacturers can now apply for up to $100,000 in matched government funding for medical technology and pharmaceutical manufacturing projects.

New MTPConnect report highlights skill gap

BioPharmaDispatch | 11 March 2021

MTPConnect released the second of three reports examining skills gaps in the medical technology, biotechnology and pharmaceutical (MTP) sector workforce and identified 20 skills gaps. The reports are being developed as part of the Researcher Exchange and Development within Industry (REDI) initiative, operated by MTPConnect for the Medical Research Future Fund.

$38 million available for research into diabetes, heart disease

Department of Health | 12 January 2021

MTPConnect, together with the Minister for Health & Aged Care, Hon. Greg Hunt MP announced that that the Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular disease is calling for Expressions of Interest (EOI) for two new Research Centres and the first round of Research Projects funding.

GSK backs MTPConnect industry-researcher initiative

Biotech Dispatch | 19 November 2020

MTPConnect announced that GSK Australia had joined the REDI initiative as a partner to fun its new PhD Graduate Innovation Program.

New initiative to accelerate research for diabetes and cardiovascular disease

Biotech Dispatch | 29 October 2020

MTPConnect announced partners for its TTRA initiative - ANDHealth, the Medical Device Partnering Program (MDPP) and UniQuest that will provide advice and mentoring for funding recipients.

Industry backs new regenerative medicine consortium

Biotech Dispatch | 29 October 2020

MTPConnect announced that it had awarded Industry Growth Centre funding to establish a regenerative medicine consortium led by AusBiotech with six industry partners. 

Funding for Brisbane-based clinical trial manufacturing facility

Biotech Dispatch | 15 October 2020

MTPConnect welcomed the funding for a new manufacturing facility at the Translational Research Institute (TRI) in Brisbane. 

Report calls for long-term investment in pandemic R&D

Stockhead | 7 October 2020

MTPConnect, in partnership with L.E.K. Consulting, released the second edition of the COVID-19 Impact Report to explore the strategies to spur recovery and discusses trends and opportunities for growth. The report makes it clear that the MTP sector has a critical and ongoing role to play in pandemic response, future preparedness and economic recovery.

‘Pharma resistance’ to battle superbugs

The Australian | 24 September 2020

MTPConnect, with support from Pfizer, MSD Australia, GSK Australia and Medicines Australia launched Australia's first Antimicrobial Resistance Network – the AAMRNet, and released a new report, ‘Fighting Superbugs: A Report on the Inaugural Meeting of Australia’s Antimicrobial Resistance Stakeholders'.

Millions in funding for virus vaccine, treatment hope

The Australian | 3 September 2020

The article covers the announcement of BTB Round 2 & 3 funding to 13 early stage medical research projects. 

Funding Boost for COVID-19 Research 

Department of Health | 3 September 2020

MTPConnect joined Minister for Health Hon. Greg Hunt MP, in the announcement of 13 early-stage medical research projects (including 5 COVID-19 projects), recieving $10.4 million in funding from BTB Rounds 2 & 3.

Surging Ahead 

AMTIL Magazine | 6 August 2020

Queensland's University of Technology (QUT)'s BridgeTech Program was highlighted in AMTIL's latest issue. BridgeTech is funded by MTPConnect with the REDI initiative. 

$18.8M investment for Australian medtech research  

Australian Manufacturing | 20 July 2020

MTPConnect announced the promising 21 research projects, funded under the third round of the BioMedTech Horizons program.

MTPConnect to administer new research accelerator

BiotechDispatch | 14 July 2020

MTPConnect launched its $47 million Targeted Translation Research Accelerator (TTRA) for Diabetes and Cardiovascular Disease, an initiative of the Medical Research Future Fund (MRFF), operated by MTPConnect. 

Accelerating diabetes and cardiovascular disease research 

Department of Industry, Science, Energy and Resources | 13 July 2020

The Minister for Industry, Science and Technology Hon. Karen Andrews MP joined Minister for Health Hon. Greg Hunt MP in the announcement of the new $47 million Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular disease, awarded to MTPConnect.

Medtech sector ready to provide jobs and attract investment  

Australian Financial Review | 13 July 2020

Our Managing Director & CEO Dr Dan Grant spoke about the potential for the MTP sector to develop in the short term post COVID-19 and more. 

COVID-19 hit, boosted medtech

Australian Financial Review | 17 June 2020 

Our Managing Director & CEO Dr Dan Grant highlighted our COVID-19 Impact Reports and the way our MTP sector and government are coming together to combat the global pandemic.

New Covid19 Research Funding

Innovation Aus | 18 May 2020

The call out for the third round of our Biomedical Translation Bridge (BTB) program, was centered around responding to the global pandemic in 12 months or less.

PM&C names digital advisory board

Innovation Aus | 1 March 2020

Our Chair Sue MacLeman, was appointed to the Prime Ministers Digital Health Advisory Committee. 

$32 million to turn more research ideas into reality 

Department of Health | 5 February 2020

MTPConnect along with our partners, were awarded REDI, a new MRFF program.

MTPConnect appoints experienced industry and R&D executive

Biotech Dispatch | 21 January 2020

Biotech Dispatch covered the announcement of our new Board member Alex Fowkes.

Startup wants to translate your tummy rumbles with AI

Sydney Morning Herald | 16 January 2020

Noisy Guts, a WA-based start-up, was awarded funding in the first round of our Biomedical Translation Bridge (BTB) Program.

Australia- India economic growth: Frugal innovation the key to driving business links for the future

Australian Manufacturing | 10 December 2019

This article highlights the launch of our report with Asialink Business and unpacking the India opportunity.

Australia takes BIO ‘by storm’ with largest ever delegation

BioWorld | 7 June 2019

BioWorld highlights the Australian delegation to BIO international convention and also features the How Global MedTech & Pharma Corporates Engage with Australia report in partnership with BioPacific Partners.

Investment in medical tech to pay healthy dividends 

Business News | 4 June 2019

One year on from creating the MTPConnect WA Hub, the story examines the achievements of the Hub in partnership with the WA Government and UWA.

This small cap biotech proves it is possible to have more women than men on a board

Stockhead | 8 March 2019 

Stockhead profiles MTPConnect's Chair Sue MacLeman on International Women's Day.

MTPConnect driving solid growth

InnovationAus | 21 February 2019

The story tracks the growth of MTPConnect from it's beginnings as part of the Department of Industry, Innovation and Science's Industry Growth Centre initiative. 

$22 million to fast track early stage research

Department of Health | 18 February 2019

The Australian Government announced the development of the Biomedical Translation Bridge (BTB) Program with partners including, BioCurate, UniQuest, the Medical Device Partnering Program (MDPP) and the Bridge Program.

MTPConnect support for industry back digital health accelerator

Biotech Dispatch | 17 January 2019

MTPConnect has backed its project ANDHealth to continue its work on enhancing the Australian digital health sector.

MTPConnect's Dr Dan Grant: A new future for medical research funding

Biotech Dispatch (also featured in Pharma Dispatch) | 20 December 2018

MTPConnect CEO authored a blog for Biotech Dispatch on the new features in the MRFF and the possibilities for the future that was announced in December.

AusBiotech congratulates MTPConnect on new funding

Biotech Dispatch | 6 Decemember 2018

When it was announced that MTPConnect would receive additional funding to 2021, AusBiotech congratulated MTPConnect on the great news.

Australia poised for global success in regenerative medicine

The Mandarin | 16 November 2018

MTPConnect CEO Dr Dan Grant wrote an opinion piece on regenerative medicine in Australia and what opportunities there are for the sector.

Hope for regenerative medicine bonanza

The Australian | 31 October 2018

The Australian exclusively covered the launch of our regenerative medicine report at the AusBiotech Conference.

Health tech funding injection to propel Australian innovations to market and into Asia

Healthcare IT | 16 October 2018

Three MTPConnect projects - the Industry Mentoring Network in STEM (IMNIS), the Medical Device Partnering Program (MDPP) and Asialinks Business - have received funding from the MTPConnect Project Fund Program. IMNIS and MDPP were part of the 2016 round of the program and Asialinks is a new project.

MTPConnect Has a New Chair

BioSpace | 4 October 2018

International publication BioSpace shared the announcement of MTPConnect's new chair Sue MacLeman, taking over from our Chair Dr Bronwyn Evans who is stepping down after nearly two years of service.

Australian government growth centres invest in life sciences sector for future global growth

BioWorld | 25 September 2018

BioWorld journalist Tamra Sami interviewed MTPConnect CEO Dr Dan Grant in WA around the launch of the MTPConnect WA hub in September.

Innovation is part of Australia's DNA. We must help commercialise it

The Australian Financial Review | 30 July 2018

Former Minister for Jobs and Innovation Senator Michaelia Cash wrote an opinion piece for the AFR in July around the AFR Innovation Summit.

MTPConnect Launches Western Australian Node

Manufacturer's Monthly | 4 July 2018

MTPConnect's Chair Dr Bronwyn Evans supported the launch of the MTPConnect WA Node in partnership with the Western Australian Government and the University of Western Australia at the Harry Perkins Institute and Centre for Medical Research.

Australia makes its mark in biotechnology

Nature Journal | 9 May 2018

MTPConnect CEO Sue MacLeman spoke with Nature, a scientific journal about how Australia is making its mark in biotechnology.

Dr Dan Grant appointed as new CEO of MTPConnect

Lab and Life Scientist | 7 May 2018

Dr Dan Grant was announced as MTPConnect's CEO-elect bringing with him many years of experience in the sector, where he will be starting in July.

"We could lead the world": Australia's MTP sector shows it's punching above its weight

Healthcare IT | 19 April 2018

MTPConnect's CEO Sue MacLeman talks to Healthcare IT about the recent announcement of the amazing innovations of the MTPConnect-delivered, Department of Health's $10 million BioMedTech Horizons program.

$1 million funding boost for UOW's 'groundbreaking' Biopen

Illawara Mercury | 19 April 2018

The article focuses on the team behind the Biopen, one of the 11 selected participants who have received funding from the MTPConnect-delivered Department of Health's $10 million BioMedTech Horizons program.

$10m in funding awarded to 11 projects to boost health innovation

Manufacturer's Monthly | 18 April 2018

MTPConnect and the Minister for Health, Greg Hunt, have announced the first 11 recipients of $10 million investment from the government’s $35 million BioMedTech Horizons program.

MTPConnect and BioPacific Partners announce new initiative

Manufacturer's Monthly | 12 April 2018

MTPConnect and BioPacific Partners has jointly launched an exciting new initiative to assist Australian medical technology and pharmaceutical companies to better prepare and position themselves to engage successfully with multinational companies.

Why investors should pay attention to biotechs focused on China

Stockhead | 15 March 2018

Chinese demand has sparked ASX-listed food and resources stocks — but health innovators may benefit most, says MTP Connect CEO Sue MacLeman. Ms MacLeman also mentions our Project Fund Program recipient's AusBiotech Asian Investment Series in Hong Kong and Shanghai.

Women and the war for talent

InnovationAus | 8 March 2018

MTPConnect CEO Sue MacLeman talks to Innovation Australia about creating gender diversity within the tech and innovation sector or lose global competitiveness in this critical arena on International Women's Day.

Strong growth in Australia's medtech, biotech and pharma sectors

Manufacturer's Monthly | 12 February 2018

MTPConnect has released new sector metrics that show jobs supported by the MTP sector increased by 10 per cent to 62,000 from 2015 to 2016, and that manufacturing exports are up by 30 per cent to $5.2 billion.

3D Printing And Precision Medicine To Get $5m In Government Funding

The Australian | 1 November 2017

Managed by MTPConnect, the $5m BioMedTech Horizons program will be managed by MTPConnect, the medical technologies and pharmaceuticals industry growth centre. MTPConnect chief executive Sue MacLeman spoke to The Australian, saying that 3D anatomical printing and precision medicine had been identified for the first share of funding because Australia punched above its weight in those areas.

Cancer Test Platform among Recipients in $22.5m Tech Funding Round For MTPConnect

Australian Financial Review | 26 October 2017

Our CEO Sue MacLeman talks about a MTPConnect Project Fund Program lead The Garvan Institute aimed to improve cancer clinical trial research.

AISC's new training package for pharma manufacturing Businesses

Manufacturer's Monthly | 11 August 2017

Our General Manager of Education, Skills and Events Dr Melanie Thomson about the training that will save pharmaceutical manufacturing businesses time and money by allowing employees to transfer basic skills between companies.

Pharma research play translates into jobs and growth

The Mandarin | 7 August 2017

An article discussing our Clinical Trials Report and how it aims to turn Australia around to be a destination for jobs and pharmaceutical investment in clinical trials.

Grant boost for medical research

Business News Western Australia | 1 November 2016

The MTPConnect Project Fund Program has provided a local WA consortium with a $150,000 grant to improve commercialisation of pharmaceutical and medical technologies.

New funding mechanism could create needed life sciences ecosystem

BioWorld | 28 October 2016

The Medical Technologies and Pharmaceuticals Industry Growth Centre (MTPConnect) announced at the recent AusBiotech annual conference that it would provide A$7.4 million (US$5.6 million) of funding over two years for 14 national projects in the med-tech, biotech and pharmaceutical sector, with the Australian government injecting more funding into its life sciences sector to help it become more globally competitive in commercializing products.

$43.4 million announced to drive innovation in pharmaceuticals and medtech around Australia

StartUp Smart | 24 October 2016

Growing investment in medical technology and pharmaceutical innovation is set to fire a new pipeline of high-impact ventures into Australia that have been hiding in the corridors of universities waiting to be commercialised. This week, non-profit organisation MTPConnect announced it will inject $7.4 million into 14 medtech, biotech and pharmaceutical projects over the next two years. The funding will be matched by a further $32 million from industry partners under MTP Connect’s project fund program.

Pill boxes and 'kneehab' apps: Johnson & Johnson hackathon

Australian Financial Review | 26 September 2016

Our CEO Sue MacLeman comments on the recent Federal Government response to the Review of Medicines and Medical Devices Regulation in this article highlighting Johnson & Johnson's potential commercialisation of two winning inventions from a hackathon earlier this month.

Forging better MedTech links

InnovationAus | 30 June 2016

Our CEO Sue MacLeman talked to InnovationAus about the achievements and challenges of the MTP sector and how MTPConnect will increase collaboration and commercialisation efforts.

A boost for innovation in medical technologies and pharmaceuticals sector

University of Sydney | 11 December 2015

Australia’s newest Growth Centre – the Medical Technologies and Pharmaceutical Industry Growth Centre – has been announced by the Hon. Christopher Pyne, Federal Minister for Industry, Innovation and Science and Minister for Health, Sussan Ley.